Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex
Open Access
- 21 May 2025
- journal article
- review article
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (5)
Abstract
Recent reports support the startling conclusion that peripheral nociceptors, the first link in pain transmission, are sexually dimorphic. The mechanisms promoting pain in men and women are therefore likely to be different, suggesting the need to consider patient sex as a factor in managing pain and painful conditions such as migraine. Many patients do not achieve sufficient benefit from available therapies and migraine therefore remains a major unmet medical need. The concept of sexual dimorphism in pain mechanism reveals previously unrecognized gaps in knowledge of migraine pathophysiology and in treatment outcomes. As migraine is highly female prevalent, our knowledge is based on studies conducted predominately in women. Data from these studies have rarely been analyzed and reported based on sex, limiting our interpretation of the occurrence, timing and severity of disease symptoms as well as possible differences in treatment efficacy in men. Inclusion of a higher proportion of men in both mechanistic investigations and clinical trials is therefore needed. Advancing our knowledge and improving therapeutic outcomes will require both preclinical and clinical investigations that address the contribution of sex in headache pain and other non-painful symptoms of migraine that impact the quality of life for patients. This viewpoint highlights the importance of considering sex as a variable in advancing our understanding of migraine pathophysiology and therapy. Consideration of patient sex could influence current clinical practice and the design of clinical studies.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS120395)
This publication has 34 references indexed in Scilit:
- Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectivesThe Lancet, 2025
- Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of MigraineJAMA Neurology, 2023
- Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk allelesNature Genetics, 2022
- Meningeal CGRP‐Prolactin Interaction Evokes Female‐Specific Migraine BehaviorAnnals of Neurology, 2021
- Amylin Analog Pramlintide Induces Migraine‐like Attacks in PatientsAnnals of Neurology, 2021
- Patterns of prolactin secretionMolecular and Cellular Endocrinology, 2020
- Human models of migraine — short-term pain for long-term gainNature Reviews Neurology, 2017
- Sex differences in the epidemiology, clinical features, and pathophysiology of migraineThe Lancet Neurology, 2017
- The Prevalence and Disability Burden of Adult Migraine in England and their Relationships to Age, Gender and EthnicityCephalalgia, 2003
- Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study IIHeadache: The Journal of Head and Face Pain, 2001